Estimate the DLT probability at each dose under the constraint that toxicity does not decrease with dose, using the pool adjacent violators algorithm.
Arguments
- n_pts
Integer matrix with one row per trial and one column per dose, or a vector for a single trial, giving the number of patients treated.
- n_tox
Integer matrix or vector of the same shape as
n_pts, giving the number of DLTs observed.- admissible
Logical matrix of the same shape as
n_pts, orNULL. Doses that areFALSEare left out of the estimation and returned asNA. Defaults to all doses that have treated at least one patient.
Value
A numeric matrix with one row per trial and one column per dose. Doses that
did not enter the estimation are NA.
Details
Pseudo-counts of 0.05 DLTs and 0.1 patients are added before the fit, and
doses are pooled with inverse variance weights. Doses left out through
admissible do not influence the estimates of the remaining doses,
which matters when eliminated doses must be excluded before selecting the
MTD.
References
Liu S. and Yuan, Y. (2015). Bayesian Optimal Interval Designs for Phase I Clinical Trials. Journal of the Royal Statistical Society: Series C, 64, 507-523.
Examples
# A single trial
boin_isotonic(n_pts = c(3, 6, 9, 12), n_tox = c(0, 1, 3, 4))
#> [,1] [,2] [,3] [,4]
#> [1,] 0.01612903 0.1721311 0.3349084 0.3349084
# Several trials at once
n_pts <- matrix(c(3, 6, 9, 12,
3, 6, 9, 12,
3, 6, 9, 12), nrow = 3, byrow = TRUE)
n_tox <- matrix(c(0, 1, 3, 4,
0, 0, 2, 3,
1, 2, 4, 6), nrow = 3, byrow = TRUE)
boin_isotonic(n_pts, n_tox)
#> [,1] [,2] [,3] [,4]
#> [1,] 0.01612903 0.17213115 0.3349084 0.3349084
#> [2,] 0.01000763 0.01000763 0.2252747 0.2520661
#> [3,] 0.33703115 0.33703115 0.4450549 0.5000000
